Anadarajah Clinical Research

Allan Anandarajah, M.D.

     Dr. Anandarajah has secured funding for his clinical research interests. He is currently developing and validating a MRI scoring system for rheumatoid arthritis. The scoring system will be used to evaluate changes in MRI findings following anti-TNF therapy in patients. He is also interested in studying generalized bone loss in psoriatic arthritis.

Publications

     Dr. Anandarajah's most recent publications include:

Anandarajah AP, Totterman S, Schwarz EM and Ritchlin CT. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow edema in patients with psoriatic arthritis . In press.

Reddy SM, Reed G, Anandarajah AP et al. Comparative analysis of disease activity, radiographic features and bone density in psoriatic and rheumatoid arthritis. Arthritis Rheum. in press.

Anandarajah AP, Ritchlin CT. Infliximab in psoriatic arthritis. Future Rheumatology. (Feb 2007)

Anandarajah AP, Schwarz EM: Anti-RANKL therapy for inflammatory bone disorders: mechanisms and potential clinical applications. J Cell Biochem. 2006; 97 (2): 226-32.

Anandarajah AP, Ritchlin CT Update on the treatment of spondyloarthropathies. Curr Opin Rheum 2005; 17 (3): 247-256.

For a complete list of Dr. Anandarajah's publications, please use this link: publications.